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ABSTRACT 
Background: Catheter-associated urinary tract infections (CAUTI) are one of the most 
common hospital-associated infections. Recent efforts to characterize the etiology and 
reduce incidence of CAUTIs have been spurred by the Centers for Medicare and 
Medicaid Services (CMS) decision to cease reimbursement for CAUTI. To have a 
national standardized definition for CAUTI for national improvement efforts and public 
reporting, many agencies including CMS, have opted to use the National Healthcare 
Safety Network (NHSN) CAUTI definition. The NHSN CAUTI definition was 
developed for surveillance efforts and therefore does not necessarily reflect clinical 
practice.  
Objectives: The objective of this study is to determine the extent to which NHSN 
reported CAUTI events correspond with clinician diagnosis of CAUTI at a University-
Affiliated Tertiary Care Hospital.  
Methods: This study is a retrospective chart review analysis of all CAUTI events 
reported to NHSN from July 1, 2010 through June 30, 2013. Patient medical records were 
reviewed to determine clinician and Infectious Disease (ID) consultant CAUTI diagnosis.  
Results: A total of 102 NHSN CAUTI events were reported over the 3-year period. Of 
these, 66.67% meet the clinician CAUTI diagnosis and 41.67% meet the ID consult 
CAUTI diagnosis.  
Jeremy Martinson, DPhil 
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Conclusions: These results suggest a poor correlation between NHSN reported CAUTI 
events and actual clinical practice, with only two thirds of the NHSN reported CAUTI 
events being diagnosed by a clinician and only 42% being diagnosed by an Infectious 
Disease consultant. As long as the NSHN-CAUTI definition is used for public reporting, 
it is important to realize that the reported rates are not necessarily reflective of infectious 
complications of urinary catheters or clinical diagnosis. Instead, these rates should be 
evaluated to identify areas for improvement within the reporting facilities and when 
addressing national improvement efforts. 
Public Health Significance: The NHSN CAUTI definition was developed for 
surveillance purposes and is therefore very broad to capture all possible CAUTI events. 
Since the NHSN surveillance definition is being used for public reporting, the reported 
CAUTI rates may be artificially inflated and thus may not truly reflect patient care at any 
given hospital. This makes it difficult for a consumer to legitimately compare hospitals 
when determining where to receive care, as the rate may be more reflective of the 
frequency of obtaining urine cultures than of actual CAUTI events.  
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1.0   INTRODUCTION 
Urinary tract infections (UTIs) are one of the most commonly reported hospital-acquired 
infections (HAI), accounting for 15% to 30% of all HAI reported by hospitals [1, 2]. The 
National Healthcare Safety Network (NHSN) reports that nearly 75% of UTIs acquired in 
hospitals are associated with urinary catheters [3]. Indwelling urinary catheters are often 
essential in critically ill patients and are used in 65% of patients in Critical Care Units 
(CCU) and in approximately 20% patients on the general wards [3]. The use of urinary 
catheters is warranted in many cases, but many catheters are used unnecessarily and for 
prolonged periods of time [4, 5]. Inappropriate use of urinary catheters puts patients at an 
increased risk for both infectious and noninfectious complications [6, 7], leads to overuse 
of antimicrobials and contributes to the rise of antimicrobial resistance, and increases 
healthcare costs [8, 9].   
Recent efforts to characterize the etiology and reduce the incidence of CAUTI 
have been spurred by the Centers for Medicare and Medicaid Services (CMS) decision to 
no longer reimburse hospitals for CAUTI as it was determined to be a preventable HAI 
[10]. CMS has also recently establish rules for public reporting of CAUTI events in 
critical care units, inpatient rehabilitation facilities and long term care hospitals as of 
2012 as well as all medical/ surgical wards by January 2015 [11]. To have a national 
   
2 
standardized definition for CAUTI for national improvement efforts and public reporting, 
many agencies including CMS, have opted to use the NHSN CAUTI definition.  
The NHSN definition of CAUTI was developed for use in surveillance and, for 
this reason, is very broad to ensure that it captures all hospital acquired CAUTI events 
and therefore does not necessarily take clinical definitions into account. Because the 
NHSN definition is so sensitive, it has the potential gather false CAUTI events, which 
may result in a poor predictive value (PPV) for identifying true CAUTI. In fact, a recent 
study found that the NHSN CAUTI definition has a PPV of 35% when using the 
Infectious Disease physician diagnosis of CAUTI as the gold standard and PPV of 62.2% 
when compared to clinician diagnosis of CAUTI [12]. 
The purpose of this study is to determine the extent to which NHSN reported 
CAUTI events correspond with clinician diagnosis of CAUTI over a three-year period 
within a University-Affiliated Tertiary Care Hospital in the state of Pennsylvania. 
Secondary aims of the study are to describe the incidence and etiology of CAUTI and to 
characterize the patient population that experience said CAUTI events. 
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2.0  BACKGROUND 
2.1 NHSN AND INFECTION CONTROL 
The National Healthcare and Safety Network (NHSN) is an internet-based surveillance 
system to track healthcare associated infections that is managed by the Division of 
Healthcare Quality Promotion at the Centers for Disease Control and Prevention [13]. 
Healthcare facilities that participate in reporting programs operated by the Centers for 
Medicare and Medicaid Services (CMS) can do so through use of NHSN. In addition, 
some U.S. states, such as Pennsylvania, utilize NHSN as a means for healthcare facilities 
to submit data on healthcare associated infections mandated through state legislation.  
2.1.1 Surveillance 
Enrollment in NHSN is optional and healthcare facilities can choose which modules they 
participate in (ex. urinary tract infections and catheter-associated urinary tract infections, 
pneumonia and ventilator-associated pneumonia, Clostridium difficile infections, surgical 
site infections, blood stream infections and catheter-associated blood stream infections, 
etc). Most modules require active, patient-based, prospective surveillance of events and 
their corresponding denominator data (ex. catheter days) by a trained Infection 
Preventionist (IP). IPs are highly trained experts working in healthcare facilities that 
conduct active surveillance of HAIs using standardized surveillance definitions created 
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by NHSN. In addition, most IPs provide patient and staff education and participate in 
process improvement projects. During a patient’s stay, IPs actively seek out infections by 
screening a variety of data sources, such as laboratory, pharmacy, 
admission/discharge/transfer, radiology/imaging, and pathology databases, as well as 
patient charts, including history and physical exam notes, nurses/physicians notes, 
temperature charts, etc. to identify any healthcare-associated infections.  
2.2 CATHETER-ASSOCIATED URINARY TRACT INFECTIONS 
2.2.1 Definitions 
NHSN defines a healthcare-associated infection (HAI) as a localized or systemic 
condition resulting from an adverse reaction to the presence of an infectious agent(s) or 
its toxin(s) that was not present on admission to the acute care facility and occurs on or 
after the third calendar day of admission [14].  
 Catheter-associated UTI (CAUTI) is defined by NHSN as a UTI where an 
indwelling urinary catheter was in place for >2 calendar days on the date of event, with 
day of device placement being Day 1, and an indwelling urinary catheter was in place on 
the date of event or the day before, and at least 1 of the following signs or symptoms: 
fever (>38°C); urgency; frequency; dysuria; suprapubic tenderness; costovertebral angle 
pain or tenderness and a positive urine culture of ≥103 colony-forming units (CFU)/ml 
with no more than 2 species of microorganisms. If an indwelling urinary catheter was in 
place for > 2 calendar days and then removed, the UTI criteria must be fully met on the 
day of discontinuation or the next day [14] (for a complete definition, see Appendix A). 
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 An indwelling catheter is defined by NHSN as a drainage tube that is inserted into 
the urinary bladder through the urethra that is left in place, and is connected to a drainage 
bag (including leg bags), also called a Foley catheter. This does not include condom or 
straight in-and-out catheters or nephrostomy tubes or suprapubic catheters.  
 Although this study focuses on CAUTI events reported to NHSN using NHSN 
definitions for identifying a CAUTI event, it is important to note a few other definitions. 
In particular, bacteriuria and asymptomatic bacteriuria (ASB). According to the 
Infectious Diseases Society of America (IDSA), bacteriuria is a significant amount of 
bacteria in urine, which is usually considered to be ≥ 103 cfu/ml for a catheterized 
specimen and ≥ 105 cfu/ml for non-catheterized specimens. IDSA defines a UTI as 
significant bacteriuria in a patient with symptoms or signs attributable to the urinary tract 
and no alternate source. Asymptomatic bacteriuria (ASB) is defined as significant 
bacteriuria in a patient without symptoms or signs attributable to the urinary tract [15]. 
 Several studies have found that asymptomatic bacteriuria (ASB) will be present in 
virtually every long-term catheter user once the catheter has been in place > 30 days [16, 
17] and approximately 75% to 90% of patients with ASB will not develop a systemic 
inflammatory response or other signs or symptoms attributable to a UTI [18, 19] 
2.2.2 Signs and Symptoms 
NHSN lists signs and symptoms of a UTI or CAUTI as the one or more of the following: 
fever (>38°C); urgency*; frequency*; dysuria*; suprapubic tenderness*; costovertebral 
angle pain or tenderness*[14]. The starred symptoms can only be used to define a CAUTI 
event if those symptoms cannot be attributable to any other cause. Note: if fever is 
   
6 
present, it is always used to define a CAUTI event, even if it can be attributed to another 
cause.  
According to the Infectious Diseases Society of America (IDSA) 2009 Guidelines 
for the Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract 
Infection in Adults; CAUTI is defined by the presence of symptoms or signs compatible 
with UTI with no other identified source of infection along with ≥103 colony-forming 
units (cfu)/mL of ≥1 bacterial species in a single catheter urine specimen or in a 
midstream voided urine specimen from a patient whose urethral catheter has been 
removed within the previous 48 hours [15] (for complete IDSA definition, see Appendix 
B).  
IDSA lists signs and symptoms compatible with UTI or CAUTI as one or more of 
the following: new onset or worsening of fever, rigors, altered mental status, malaise, or 
lethargy with no other identified cause, flank pain, costovertebral angle tenderness, acute 
hematuria, pelvic discomfort, and in those whose catheters have been removed; dysuria, 
urgent or frequent urination, or suprapubic pain or tenderness. In patients with spinal cord 
injury, increased spasticity, autonomic dysreflexia, or sense of unease are also compatible 
with CAUTI [15].  
In addition, the IDSA CAUTI guidelines state that pyuria (≥10 WBC/mm3 in 
unspun urine or >5 WBC/ hpf (high power field) in spun urine found in a urine specimen 
is not considered to be diagnostic of CA-bacteriuria or CAUTI and the presence or 
absence of pyuria should not be used to differentiate CA-ASB from CAUTI nor should 
pyuria be considered as an indicator for antimicrobial treatment of CA-ASB. Also, in 
catheterized patients, the presence or absence of odorous or cloudy urine alone should not 
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be used to differentiate CA-ASB from CAUTI or as an indication for urine culture or 
antimicrobial therapy [15]. 
 Many studies have found that symptoms are not reliable for the diagnosis of 
CAUTI. In a large prospective study by Tambyah et al, the authors were unable to 
demonstrate a difference between symptomatic CAUTI and asymptomatic bacteriuria in 
the presence of fever or symptoms related to the urinary tract in catheterized patients with 
or without CA-asymptomatic bacteriuria [20]. Tambyah et al. states that the urinary 
catheter itself can often be the source of symptoms, as the proportion of catheterized 
patients without CAUTI that experienced symptoms was similar to those with CAUTI.  
 It has been found that many patients with a urinary catheter do not experience any 
of the typical symptoms associated with a UTI such as dysuria or supra-pubic pain 
because the catheter itself prevents contact of inflammatory cells in urine and large 
numbers of microorganisms with the urethral mucosa [21]. The presence of the urinary 
catheter also allows for decompression of the bladder and therefore prevents symptoms 
related to bladder distension or reflux [21]. Interestingly, it has also been shown that 
febrile episodes rarely occur in patients with long-term indwelling catheters even though 
they experience significant amounts of bacteriuria [22, 23].  Likewise, in a retrospective 
cohort study of patients who had experienced trauma, neither fever nor leukocytosis was 
associated with CAUTI [24]. The authors concluded that there was an unnecessary 
emphasis on UTI as a source of fever and leukocytosis in patients hospitalized in the 
intensive care unit (ICU).  
 In March of 2012, the CDC/NHSN sent out a newsletter stating that fever can be 
attributed to many different HAIs, such as CAUTI and pneumonia, and it is often 
   
8 
impossible to distinguish which infection is the root cause so the fever must be attributed 
to all possible causes [25]. This change in definition was an attempt to prevent healthcare 
facilities from selectively choosing which type of HAI to attribute the fever to, however, 
this may cause more physicians to diagnose and treat patients for a CAUTI even though 
the patient may have CA-bacteriuria and the fever is due to another reason. This also has 
the potential to lead to an increased number of CAUTI events being falsely reported to 
NHSN and CMS and subsequently hospitals performance scores. 
2.2.3 Treatment 
IDSA suggests a urine specimen for culture should be obtained prior to initiating 
antimicrobial therapy for a presumed CAUTI because of the wide spectrum of potential 
infecting organisms and the increased likelihood of antimicrobial resistance [15]. The 
IDSA guidelines also specifically state “catheterized patients should be thoroughly 
evaluated for the source of signs and symptoms before attributing them to the urinary 
tract and initiating antimicrobial therapy”[15]. IDSA recommends the following 
treatment guidelines for patients found to have CAUTI [15]: 
Seven days is the recommended duration of antimicrobial treatment for patients 
with CAUTI who have prompt resolution of symptoms, and 10–14 days of treatment is 
recommended for those with a delayed response, regardless of whether the patient 
remains catheterized or not.  
i. A 5-day regimen of levofloxacin may be considered in patients with CAUTI 
who are not severely ill. Data are insufficient to make such a recommendation about 
other fluoroquinolones.  
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ii. A 3-day antimicrobial regimen may be considered for women aged ≥65 years 
who develop CAUTI without upper urinary tract symptoms after an indwelling catheter 
has been removed. 
2.3 EPIDEMIOLOGY AND PATHOGENESIS 
The incidence of bacteriuria associated with indwelling catheterization is 3%–8% per 
catheter day [23, 26-28], with almost universal bacteriuria with long-term catheterization 
of > 30 days [16, 17]. It has also been found that the duration of catheterization is the 
most important risk factor for the development of CA-bacteriuria [16, 29]. Other risk 
factors that have been found to be associated with CA-bacteriuria include not receiving 
systemic antimicrobial therapy, female sex, microbial colonization of the drainage bag, 
catheter insertion outside the operating room, catheter care violations, fatal underlying 
illness, older age, diabetes mellitus and other sites of infection at the time of 
catheterization [16, 26, 29, 30]. 
The urinary catheter disrupts host defense mechanisms and allows for easy access 
of uropathogens to enter the bladder [31, 32]. There are two main modes for microbes to 
gain entry into the urinary tract during catheterization, that is either extraluminal or 
intraluminal. Microbes utilize the extraluminal route either at the time of catheter 
insertion or when perineal bacteria move up along the outer surface of the catheter into 
the bladder [33]. Microbial entry occurs intraluminally when contaminated urine enters 
the bladder from the collection bag or when there is a break in the closed drainage system 
[34]. A prospective study by Tambyah, et al [34] found that 66% of the identified 
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CAUTIs were extraluminally acquired, 18% occurred early (detected within 24 h) while 
48% occurred later (around 6 days after catheterization), and 34% were acquired 
intraluminally. Infections caused by gram-positive cocci (staphylococci and enterococci) 
and yeast were mostly extraluminal, whereas gram-negative infections occurred 
approximately equally through either route. Additionally, patients appear to remain at an 
increased risk of bacteriuria for at least 24 h even after removal of the catheter [27], 
which seems to suggest that colonization of the urethra persists even after the catheter is 
removed. 
A urinary catheter also allows for the formation of a biofilm, which is central to 
the development of CAUTI.  Formation of biofilms by microbes on the surface of a 
urinary catheter and in the drainage system will inevitably occur with long-term 
catheterization [35]. Initially, biofilms are comprised of one bacterial species, but 
eventually become polymicrobial with long-term catheterization [15]. The organisms that 
form these biofilms are often extremely antimicrobial resistant due to the high rate of 
genetic material exchanged between the organisms comprising the biofilm [36]. In 
addition to being extremely antimicrobial resistant, microbes within a biofilm are also 
resistant to host defenses, making them virtually impossible to eradicate without 
removing the catheter [37]. 
The majority of organisms that cause CAUTI are commensal perineal, rectal or 
vaginal flora. However, bacteria acquired from the hands of health-care personnel have 
also been implicated [38]. The most commonly implicated bacteria associated with 
CAUTI reported to NHSN (combining both ASB and SUTI) is Escherichia coli (21.4%) 
and Candida spp. (21.0%), followed by Enterococcus spp (14.9%), Pseudomonas 
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aeruginosa (10.0%), Klebsiella pneumoniae (7.7%), and Enterobacter spp (4.1%) with a 
smaller proportion caused by other gram-negative bacteria and Staphylococcus spp. [37, 
39]. 
2.4 IMPACT OF CAUTI 
2.4.1 Length of Stay 
Studies conducted in the early eighties found that the additional length of stay attributable 
to CAUTI was 2–4 days [40-42]. However, a 2011 meta-analysis of 11 observational 
studies analyzing outcome of catheter-associated urinary tract infections found that 
CAUTI was significantly associated with an increased length of stay of 12 days in the 
intensive care unit (95% CI, 9-15 days) and an increased hospital length of stay of 21 
days (95% CI, 11-32 days) [43]. 
2.4.2 Morbidity and Mortality 
There seems to be little consensus on the effect of CA-bacteriuria on mortality. A 
prospective study by Platt et al [44] reported an adjusted odds ratio of 2.8 for mortality in 
patients with an indwelling catheter who acquired CA-bacteriuria compared to those who 
did not. A meta-analysis and review of 11 observational studies found that CAUTI was 
associated with increased crude mortality, with an odds ratio of 1.99 [43]. This increase 
in mortality among catheterized patients is thought to be associated with secondary 
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bacteremia and septicemia [38]. On the other hand, several studies have suggested that 
the association with mortality is most likely explained by confounding, as most 
catheterized patients tend to be more sick and functionally impaired [22, 45]. 
CAUTI can also lead to complications such complications as cystitis, 
pyelonephritis, periurethral abscess, gram-negative bacteremia, prostatitis, epididymitis, 
and orchitis in males and, less commonly, endocarditis, vertebral osteomyelitis, septic 
arthritis, endophthalmitis, and meningitis in all patients [14, 17]  
2.4.3 Contribution to the Rise of Antimicrobial Resistance 
In general, physicians typically view CAUTI as low risk to patients, with low rates of 
progression from CAUTI to bactermia or fungemia [19, 46]. However, despite this 
perception of minimal risk, CAUTI is frequently treated with antimicrobials even in 
asymptomatic patients, with over one-third of antimicrobial use inappropriately aimed at 
treatment of asymptomatic bacteriuria [47, 48]. This inappropriate use of antimicrobials 
may be a contributing factor to the rise in antimicrobial resistant microbes and 
subsequent increases in healthcare costs. 
 When a patient is exposed to antimicrobials, it applies selective pressures on 
bacteria inhabiting the patient and the bacteria will try to develop ways to resist the 
drug’s effects, therefore reducing their susceptibility [49]. Since resistance arises with 
antibiotic use, it is important to use antibiotics sparingly and only when clinically 
indicated. Antibiotic use is especially common in healthcare facilities with around 25% 
of all hospitalized patients receiving antibiotics at least once during their hospitalization 
[49]. Inappropriate use of antibiotics, including inappropriate dosages and durations, or 
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treating a patient with antimicrobials when it is not clinically indicated is contributing to 
the problem of antimicrobial resistance. Studies have shown that “antibiotic use is 
unnecessary or inappropriate in as many as 50% of cases in the United States.” [49] 
For this reason, IDSA suggests a urine specimen for culture should be obtained 
prior to initiating antimicrobial therapy for presumed CAUTI because of the wide 
spectrum of potential infecting organisms and the increased likelihood of antimicrobial 
resistance [15]. As mentioned before, IDSA states that, in the catheterized patient, the 
presence or absence pyuria or of odorous or cloudy urine alone should not be used as an 
indication for urine culture or antimicrobial therapy [15]. Although some physicians will 
treat a patient with antimicrobials based solely on these signs [50].  
 Because so many episodes of bacteriuria are inappropriately treated with 
antimicrobials and because of the high rate of biofilm formation and subsequent 
antimicrobial resistance, CAUTIs are a major reservoir of resistant pathogens [7, 51]. 
Approximately one quarter of E. coli isolates and one third of P. aeruginosa isolates from 
CAUTI cases reported to NHSN were fluoroquinolone-resistant [37]. Resistance of gram-
negative pathogens to other antimicrobials, including third-generation cephalosporins and 
carbapenems, from CAUTI events was also substantial high [39]. The proportion of 
organisms that were multidrug-resistant, defined by non-susceptibility to all agents in 4 
classes, was 4% of P. aeruginosa, 9% of K. pneumoniae, and 21% of Acinetobacter 
baumannii. [52]. 
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2.4.4 Costs 
According to the US Deficit Reduction Act that went into effect in October 2008, 
hospitals will no longer receive reimbursement for managing 'reasonably preventable' 
healthcare-associated infections. The Centers for Medicare and Medicaid Services (CMS) 
identified hospital acquired CAUTI as one of these eight conditions for which hospitals 
will not receive additional reimbursement. In a review by Umscheid et al, the authors 
found that the number of avoidable CAUTIs in the United States ranges from 95,483 to 
387,550 infections per year, the potential lives that could be saved ranged from 2,225 to 
9,031 annually, and the estimated annual costs of preventable CAUTIs are from $115 
million to $1.8 billion [5].   
 A 27 year literature review and meta-analysis found that each CAUTI event costs 
the US Health Care System $896 per person for a total of $27,884,193 per year [8]. 
CAUTIs caused by E. coli cost considerably less ($363.3/ CAUTI event) than infections 
caused by other gram-negative bacilli ($690.4/ CAUTI event) or yeasts ($821.2/ CAUTI). 
Similar to CAUTI caused by E. coli, CAUTI caused by staphylococci or enterococci has 
been shown to cost approximately $387.1/CAUTI event [18, 20]. Another study found 
that bacteremia associated with CA-bacteriuria is estimated to cost at least $2836 per 
event [20].  
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3.0  METHODS 
3.1 STUDY OBJECTIVES 
The purpose of this study is compare clinician diagnosis of CAUTI to NHSN reported 
CAUTI events over a three-year period within a University-affiliated Tertiary Care 
Hospital. Secondary aims of the study are to describe the incidence and etiology of 
CAUTI and to characterize the patient population that experience said CAUTI events.  
3.2 STUDY DESIGN 
This study is a retrospective chart review analysis of all patients admitted to a Tertiary 
Care Hospital (TCH) with a hospital stay of greater than 2 calendar days for which a 
CAUTI event was reported to the Centers for Disease Control (CDC) through the 
National Healthcare Safety Network (NHSN) from July 1, 2010 through June 30, 2013. 
3.3 STUDY AREA 
This study was developed as a quality improvement measure and was approved by the 
hospital’s Quality Improvement Committee. Data collection and analysis was overseen 
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by the department of Infection Control. The data was collected and analyzed at the TCH 
and at the University of Pittsburgh.  
 The TCH is part of a large network of hospitals in Western Pennsylvania. The 
hospital is a 495-bed facility with many inpatient and outpatient services including, but 
not limited to: orthopedic surgery, cardiology, neurology, and inpatient rehabilitation. 
The hospital also serves a Level I Burn and Trauma Center, is equipped with a fully 
functioning Emergency Department is and is affiliated with a local University.  
3.4 STUDY POPULATION 
3.4.1 Inclusion Criteria 
All patients included in the study are those that were reported to the Centers for Disease 
Control (CDC) through the National Healthcare Safety Network (NHSN), following 
NHSN CAUTI definition, by the hospital’s Department of Infection Control from July 1, 
2010 through June 30, 2013. Trained Infection Preventionists used standardized 
surveillance definitions to identify all CAUTI events (for a complete definition, please 
see Appendix A). This includes patients age >18 with a positive urine culture collected 
more than 48 hours after admission to the hospital with an indwelling urinary catheter or 
within 48 hours of catheter removal.  
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3.4.2 Exclusion Criteria 
Patients excluded from this study are those that were initially excluded by Infection 
Preventionists when the CAUTI events were originally reported to NHSN following 
NHSN CAUTI guidelines.  Patients with a positive urine culture within 48 hours of 
admission were excluded to avoid including patients that were admitted with a UTI. 
Patients with condom or suprapubic catheters and patients that were intermittently 
catheterized were also excluded form the study.  
3.5 DATA COLLECTION 
Patient information was accessed via e Record and medical charts were carefully 
reviewed using Cerner’s PowerChart, Epic, and Theradoc. Admission notes, nurses’ 
observation notes, history and physical notes, progress notes, Infectious Disease 
consultation notes, and discharge summary for each patient encounter were reviewed to 
extract patient demographics and relevant clinical and laboratory data. Data extracted was 
recorded in an Excel document.  
3.5.1 Demographic and Clinical Data Collection 
Demographic data collected includes age, race, gender, comorbidities as determined by 
the Charlson Comorbidity index, reason for admission, prior hospitalization within the 
previous year, location before admission, discharge disposition, length of hospital stay, 
time from admission to identification of CAUTI, location of catheter insertion, catheter 
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dwell time, catheter necessity, and location of patient when the positive urine culture was 
collected.  
Clinical data collected includes signs and symptoms such as temperature, dysuria 
frequency of urination, urgency of urination, suprapubic pain or tenderness, flank pain, 
and altered mental status. Pharmaceutical data collected includes empiric antimicrobials 
prescribed if a CAUTI was suspected and if a CAUTI was diagnosed, definitive 
antimicrobial prescribed and duration of definitive antimicrobial.  
Laboratory data collected includes peripheral white blood cell count, urinalysis 
results of nitrates, leukocyte esterase and urine microscopic WBC count/ hpf. If a 
urinalysis or WBC count were not performed on the day of the positive culture, results 
from the 24 hours before or 24 hours after urine collection were used, depending on 
which was more abnormal.  Microbiology data collected includes organism identified 
from the urine culture, colony count of the bacteria isolated (cfu/ul), and antimicrobial 
sensitivities. 
3.5.2 CAUTI Diagnosis 
Clinician diagnosis: Patient medical records were reviewed to determine if the patient’s 
clinician had documented the occurrence UTI and if the clinician started antimicrobial 
treatment for it.  
Infectious Disease Consult diagnosis: Consult notes were reviewed to determine if 
the patient was seen by an Infectious Disease consultant and whether the ID consultant 
documented occurrence of a UTI and recommended treatment. 
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NHSN definition diagnosis: All patients were considered to meet the NHSN 
definition of CAUTI as they were reported to the NHSN as such. See Appendix A for 
complete NHSN CAUTI definition.  
3.6 DATA ANALYSIS 
Descriptive statistics were calculated to characterize the study population with respect to 
demographic and clinical characteristics. Incidence rate of CAUTI for each fiscal year 
and overall incidence rate of CAUTI was calculated as events per 1,000 catheter days by 
dividing the total number CAUTI events by the total number of catheter days for each 
fiscal year at the hospital over the three-year period. Catheter utilization rate (CUR) for 
the same time period was calculated by dividing the number of catheter-days by patient-
days. All data was analyzed using Microsoft Excel and STATA 13.0. 
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4.0  RESULTS 
Over the 3-year period, 102 CAUTI events were reported to NHSN; 42 in fiscal year 
(FY) 2011, 23 in FY 2012, 37 in FY 2013. Overall, the hospital wide incidence rate for 
CAUTI over the three-year period was 1.26 events per 1,000 catheter days. Incidence of 
CAUTI for FY 2011 was 1.63, 0.92 in FY 2012, and 1.23 in FY 2013 (Table 1).  
Table 1. Overall Incidence Rate (IR) for CAUTI and Catheter Utilization Ratio (CUR) 
 Fiscal year 
2011 
Fiscal year 
2012 
Fiscal year 
2013 
CAUTI events 42 23 37 
CAUTI IR 1.63 0.92 1.23 
CUR 0.18 0.18 0.22 
Note. CAUTI IRs were calculated as CAUTI events per 1,000 catheter-days (CDs) and CUR was 
calculated as CDs divided by total patient-days.  
 
4.1.1 Patient characteristics  
Out of the 102 CAUTI events, 59 (57.84%) were female. The median age was 60 with 
minimum age of 18 years and maximum of 94 years. The most common reason for 
admission was a central nervous system incident (33.33%), which included conditions 
such as cerebral vascular accident, hemorrhagic stoke, cerebral thrombosis and one case 
of human herpes virus encephalitis. Other reasons for admission included surgical 
conditions (19.61%) such as total knee arthroplasty, CABG, and hysterectomy; trauma 
(15.69%), which included motor vehicle accident, gunshot wound, and burns; and other 
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reasons for admission (31.37%), which included conditions such as respiratory failure, 
chronic heart failure, COPD exacerbation, and alcohol withdrawal.  
The median length of stay at the hospital was 19 days with a minimum of 3 and a 
maximum of 128 days. A total of 54% of patients presented for admission to the facility 
from home. The remaining patients were receiving some sort of care prior to admission 
the TCH either transferring from another hospital (35.29%), coming from a nursing 
facility (6.89%), or some other form of care (3.92%) (see table 2).  In addition, 63.73% of 
the patients had been hospitalized within the previous year.  
  
                   
Table 2. Location of Patients Prior to Admission 
 
 
 
 
 
At the time of the CAUTI event, 60.78% of patients were in a Critical Care Unit 
(CCU), 20.58% were on a medical or surgical ward, and 18.64% were in inpatient 
rehabilitation. The median duration of urinary catheterization prior to urine culture was 9 
days with a minimum of 2 days and maximum of 63 days and 14.71% of patients had 
been catheterized for greater than 30 days. At the time of urine collection, 81.37% had a 
urinary catheter in place.  
One third (33.33%) of patients had a concurrent infection at the time of the urine 
culture collection. Of the 62 patients that were in critical care, 26 (41.94%) had a 
concurrent infection. The most common concurrent infection in the CCU was infectious 
Location Before Admission Total (n=102) 
Home 55 (53.92%) 
Acute care hospital 
Nursing home/ extended care facility 
            36 (35.29%) 
7	  (6.86%) 
Home nursing 2	  (1.96%) 
Inpatient rehab 
Long term hospital 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  (0.98%)	  
1	  (0.98%) 
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pneumonia (n=19, 67.86%), followed by sepsis (n=6, 21.43%), and Clostridium difficile 
(n=3, 10.71%). Two of these patients had both pneumonia and C. difficile. Of the 21 
patients on a Medical/ Surgical unit, 5 (23.81%) had a concurrent infection including 2 
with infectious pneumonia, two with Clostridium difficile, and one with sepsis. Four of 
the 19 patients (21.05%) in inpatient rehabilitation also had concurrent infections; two 
with Clostridium difficile, one with sepsis, and one with a surgical site infection. Patient 
characteristics are summarized in Table 3. 
 
Table 3. Characteristics of Patients with CAUTI 
Variable Total (n=102) 
Female sex 
Patient age, median years (IQR) 
Length of stay, median days (IQR) 
Time from admission to diagnosis, median days (IQR) 
59 (57.84%) 
60 (50-69) 
19 (12-29) 
7 (5-15) 
Hospitalization with previous year 
History of urinary tract infections (UTIs) 
65 (63.73%) 
26 (25.49%) 
Patient survived 92 (90.20%) 
Patient with another concurrent infection 34 (33.33%) 
Catheter present at time of specimen collection 83 (81.37%) 
Catheter dwell time, median days (IQR) 
      >30 days 
9 (5-17) 
15 (14.71%) 
Mean temperature (°C ± SD) 38.45 ± 0.77 
Mean peripheral white blood cell count  
(cells/mm3 ± SD) 
12.15 ± 4.74 
Reason for admission 
     Central Nervous System incident 
     Other 
     Surgical 
     Trauma 
 
34 (33.33%) 
32 (31.37%) 
20 (19.61%) 
16 (15.69%) 
Patient location at time of CAUTI 
     Critical Care Unit (CCU) 
     Medical/Surgical ward  
     Rehabilitation 
 
62 (60.78%) 
21 (20.58%) 
19 (18.64%) Note.	  Data	  are	  number	  (%)	  patients	  unless	  otherwise	  indicated.	  IQR,	  interquartile	  range.	  SD,	  standard	  deviation.	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4.1.2 Laboratory Findings and Microbiology Data 
All of the patients had a peripheral white blood cell (WBC) count drawn within 24 hours 
before or 24 hours after urine culture collection. The mean WBC count was 12.15 ± 4.74 
per mm3. Of all the patients that experienced a CAUTI event, 88.24% received a 
urinalysis (UA). Of those that had a UA, 39.22% were positive for nitrates, 83.33% were 
positive for leukocyte esterase, and 77.45% were consistent with pyuria (>5 WBC/hpf 
seen in spun urine).  
 The majority of the urine cultures were monomicrobial (79.41%) and the 
remainder had two organisms for a total of 123 organisms isolated.  The predominant 
organisms were gram-negative with most common organism isolated from the urine 
culture being Escherichia coli (39.84%), followed by Klebsiella pneumonia (9.76%), 
Pseudomonas aeruginiosa (8.13%), Proteus mirabilis (7.32%), Enterobacter species 
(4.07%), and other gram negative (5.69%). The most common gram-positive organisms 
were Enterococcous species (14.63%), followed by other gram-positive organism (n=3, 
2.44%), which includes Staphylococcus aureus (n=2) and non-hemolytic Streptococci 
(n=1). Ten of the 123 (8.13%) organisms isolated were Candida species. These results 
are consistent with other published data of CAUTI organisms. Microbiology data is 
summarized in Table 4.  
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Table 4. Microorganisms Isolated form Urine Cultures of Patients with CAUTI 
Pathogen Percentage 
(n=123) 
Remarks 
Escherichia coli 39.84% 
Enterococcous spp. 14.63% 8/18 (44.44%), VRE 
Klebsiella pneumoniae 9.76% 1/12 (8.33%), ESBL producer 
2/12 (16.67%), KPC producer 
Pseudomonas aeruginiosa 8.13% 
Candida spp. 8.13% 
Proteus mirabilis 7.32% 
Other gram negative 9.76% 
Gram positive 2.44% 
VRE, vancomycin-resistant enterococci. ESBL, extended spectrum beta-lactamase. 
KPC, Klebsiella pneumoniae carbapenemase. 
4.1.3 Patient Signs and Symptoms 
Mean patient temperature was 38.45°C ± 0.77°C. The most common sign and symptom 
that was documented in the patient’s chart as being associated with the UTI was fever 
(58.82%).  Signs and symptoms commonly associated with a UTI such as dysuria 
(4.90%), frequency (3.92%), urgency (3.92%), and burning (0.98%) were noted in a few 
of the patients that did not have catheters at the time of urine collection. Only one patient 
was noted to have flank pain (0.98%). For some patients, incontinence (n=7, 6.86%), 
altered mental status (n=3, 2.94%), and leukocytosis (n=3, 2.94%) were documented, 
none of which are considered to be signs or symptoms attributable to a UTI according to 
NHSN (see Appendix A). A total of 26 (25.49%) patients had no documented symptoms 
at all (see table 5).  
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Table 5. Signs and Symptoms of Patients with CAUTI 
Signs and Symptoms Total (%) 
(n=102) 
Fever 60 (58.82%) 
No documented symptoms 
Incontinence 
26 (25.49%) 
7 (6.86%) 
Dysuria 5 (4.90%) 
Urinary frequency 
Urinary urgency 
4 (3.92%) 
4 (3.92%) 
Leukocytosis 3 (2.94%) 
Altered mental status 3 (2.94%) 
Flank pain 1 (0.98%) 
Burning 
SIRS 
1 (0.98%) 
1 (0.98%) 
 
4.1.4 Reason for Ordering Urinalysis and Urine Culture 
The most common reason for ordering a UA and urine culture documented in the 
patient’s charts was a pan culture (requesting all possible cultures at once) for fever 
and/or leukocytosis (37.25%). Twenty-eight (27.45%) of the urine cultures were 
performed with no documented reason. Other documented reasons for ordering a urine 
culture consistent with a UTI included; fever (16.67%), dysuria (4.90%), frequency 
(2.94%), urgency (2.94%), flank pain (0.98%). Documented reasons not consistent with 
the NHSN UTI definition include; incontinence (5.88%), leukocytosis (3.92%), cloudy 
urine (3.92%), systemic inflammatory response syndrome (SIRS) (0.98%), condition C 
(0.98%), and foul smelling urine (0.98%) (see table 6). 
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Table 6. Reason for Ordering Urine Culture 
 
 
 
 
 
 
4.1.5 CAUTI Diagnosis and Treatment 
Of the 102 CAUTI events reported to NHSN, 68 (66.67%) patients meet the clinician 
diagnosis definition, where the clinician mentioned of the occurrence of a UTI in the 
patient’s records and the patient was subsequently treated with antimicrobials. An 
Infectious Disease (ID) Consultant was involved in the care of 24 (23.53%) of the 
patients. Of these 24 patients, 10 (41.67%) patients meet the ID consult CAUTI 
diagnosis, where the ID consultant documented in the patient’s records the presence of 
UTI and recommended treatment. All 10 of theses patients were treated with 
antimicrobials, but 2 did not meet the clinician diagnosis definition, as the clinician never 
mentioned the presence of a UTI in the patient’s records. In addition, ID consultants 
Reason for Ordering Urine Culture Total (%) 
(n=102) 
Pan culture for Fever or Leukocytosis 38 (37.25%) 
No documented reason 
Fever 
28 (27.45%) 
17 (16.67%) 
Incontinence 6 (5.88%) 
Dysuria 
Leukocytosis 
Cloudy urine 
5 (4.90%) 
4 (3.92%) 
4 (3.92%) 
Frequency 3 (2.94%) 
Urgency 3 (2.94%) 
SIRS 1 (0.98%) 
Flank pain 
Condition C 
Foul smell 
1 (0.98%) 
1 (0.98%) 
1 (0.98%) 
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documented the presence of colonization or asymptomatic bacteriuria in 5 (20.83%) of 
the patients seen.  
Antimicrobial treatment was initiated in 80 (78.43%) of the patients, meaning that 
12 patients were not diagnosed with a UTI by either their clinician or an ID consultant 
but were treated with antimicrobials. For two of the patients, antimicrobials were stopped 
after 2 days of treatment from a recommendation of the ID consultant that the patient’s 
Foley was colonized. Four of these patients had urine cultures positive for Candida and 
were treated with fluconazole for “persistent funguria.” Medical records reveal that 
another four of these patients were being treated solely because of a “positive urine 
culture.” Interestingly, for the other two patients, it was specifically noted in the patient’s 
chart that they were asymptomatic and the positive culture was due colonization but they 
were treated with antimicrobials anyway.  
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5.0  DISCUSSION 
5.1 SUMMARY OF RESULTS 
The hospital wide CAUTI incidence rate per 1,000 catheter days was 1.63 for fiscal year 
2011, 0.92 for fiscal year 2012, and 1.23 for fiscal year 2013. Overall CAUTI incidence 
for the three-year period was 1.26 events per 1,000 catheter days. These rates are 
consistently less than the 2011 Pennsylvania benchmark of 1.71 CAUTI events per 1,000 
catheter days.  
CAUTI was more common in women, patients of older age, critically ill and in 
people with other sites of infection. These patient characteristics are consistent with risk 
factors found in other published data [26, 29, 30]. Additionally, the microbiology results 
are similar to data reported to NHSN with predominately gram-negative organisms being 
isolated and E. coli being the most common pathogen found [39]. Similar to previous 
studies, this study also found that administering antimicrobials for catheterized patients 
with asymptomatic bacteriuria was common practice [48].  
Only 66.67% of the NHSN CAUTI events over the three-year period meet the 
clinician diagnosis definition. Of the 24 cases seen by an ID consultant, only 10 (41.67%) 
meet the ID diagnosis definition. These numbers are similar to those found in a recent 
study published by Al-Qas Hanna et. al., where the authors found that the NHSN CAUTI 
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definition had a positive predictive value (PPV) of 35% when using an Infectious Disease 
physician diagnosis of CAUTI as the gold standard and a PPV of 62.2% when compared 
to clinician diagnosis of CAUTI [12]. These results suggest that at least one third of 
CAUTI events reported NHSN are not true CAUTI.  
5.2 SIGNS AND SYMPTOMS  
Catheter-associated urinary tract infections are traditionally difficult to diagnosis. In this 
study only 11 out of 102 patients had signs or symptoms classically associated with a 
UTI, such as dysuria, urgency, and flank pain, similar to a previously study [19]. This 
lack of focal signs and symptoms makes the diagnosis of CAUTI challenging and based 
on excluding other infections. Furthermore, almost two thirds of the patients were in 
critical care where patients are traditionally more ill, may not be able to convey urinary 
tract symptoms, and have a greater tendency to be febrile when compared to other units 
in a hospital.  
Many of the documented signs and symptoms such as incontinence, leukocytosis, 
cloudy urine, and foul smelling urine are not considered be signs or symptoms of a 
urinary tract infection by either IDSA or NHSN. According to IDSA, no studies have 
demonstrated that odorous or cloudy urine in a catheterized individual, even if these 
findings are new, has clinical significance [15]. Also, studies have found that for a 
hospitalized patient with an indwelling urinary catheter, peripheral leukocytosis has little 
predictive value for the diagnosis of CAUTI [19]. Therefore, if physicians were better 
educated on what signs and symptoms warrant obtaining a urine culture, the number of 
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non-clinical CAUTI events needlessly reported to NHSN would be decreased (see 
Appendix B for IDSA guidelines). 
Fever was documented in the medical records of 60 (58.82%) patients as being 
attributable to a urinary tract infection. For 57 (55.90%) of these patients, fever was the 
only documented symptom. In fact, according to NSHN data, fever is the only sign or 
symptom in greater than 85% of CAUTIs reported to NHSN [53]. Of the 57 patients with 
fever only, 18 (31.58%) were not diagnosed as having a UTI nor were they treated with 
antibiotics. By eliminating the reporting of UTIs that are diagnosed by fever alone and 
are not treated with antimicrobials, NHSN could increase the specificity of the CAUTI 
definition to more truly reflect clinical practice and patient outcome. At this hospital, this 
simple definition change would reduce the CAUTI rate by 17.65% over the three-year 
period.  
Out of the 38 patients with CAUTI that were found as a result of panculture for 
fever or leukocytosis, 18 had a concurrent infection and two had a maintained fever of 
greater than 38°C. Infectious Diseases Society of America (IDSA) guidelines for 
diagnosis of a CAUTI specifically state that fever is a compatible sign or symptom of 
CAUTI only if it is new onset or worsening and cannot be attributed to another cause. 
None of the patients with concurrent infections or maintained fever had signs or 
symptoms attributable to a UTI except for the fever. Cohorts of highly skilled infectious 
disease specialists come together to create the IDSA clinical practice guidelines to assist 
healthcare providers in properly diagnosing infectious diseases and infectious 
complications. By taking these clinical guidelines (see Appendix B) into consideration, 
and excluding fever as a sign or symptom of CAUTI if it can be attributed to another 
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source, the NSHN definition would again more truly reflect clinical practice and patient 
outcome. By making this definition change, CAUTI rates would be decreased by as much 
19.61% at this hospital. 
5.3 AREAS FOR HOPSITAL IMPROVEMENT 
The burden of change does not fall solely on the National Healthcare and Safety 
Network. There are many changes in hospital policy and regulation that can be put into 
action to reduce the number of false CAUTI events needlessly reported to NHSN as well 
as the incidence of true CAUTI.  
5.3.1 Elimination of Panculture 
Fever is relatively common in critically ill and trauma patients and because a fever can be 
a symptom of infection as well as other noninfectious inflammatory responses, it is 
important to thoroughly analyze febrile patients to identify the source of fever.  
Unfortunately, a common practice among clinicians used to identify the source of fever is 
panculture. Panculture typically refers to the practice of obtaining sputum, urine, and 
blood cultures on a febrile patient without considering clinical symptoms, or abnormal 
results form a urinalysis or chest x-ray [54]. This practice results in a large number of 
negative cultures and unnecessary healthcare costs. It has been found that these 
unnecessary cultures do not alter the outcome of most of the patients and the cause of 
fever can typically be identified with a careful review of the patient's history, medical 
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record, and physical examination [55]. It is also important to consider other noninfectious 
causes of fever, such as underlying comorbid disease (ex. autoimmune disease or gout), 
recent procedures (ex. blood transfusion or operation), trauma, current medications, deep 
vein thrombosis or pulmonary embolism, and alcohol/ drug withdrawal [56, 57].   
The fact that over one third (37.25%) of the NHSN reported CAUTI events over 
the three-year period were identified via panculture for fever, the practice of “pan-
culturing” at this hospital appears to be a common course of action for febrile patients. 
The practice of panculture should not be condoned and clinicians should instead be 
encouraged to critically evaluate febrile patients for the source of fever (infectious or 
noninfectious) before ordering cultures. By implementing policies to regulate the use of 
urine cultures and developing clinical algorithms for obtaining cultures and initiating 
antimicrobial treatment in febrile patients, the use of indiscriminant cultures could be 
greatly reduced.  
In an attempt to decrease the random use of urine cultures, blood cultures, and 
chest x-ray films, one study found a 5-fold decrease in the number of cultures ordered on 
postoperatively febrile patients and an 8-fold increase in positive test results, resulting 
thousands of dollars saved all with the implementation of a fever algorithm based on 
symptoms and physical examination [58]. According to guidelines for the evaluation of 
fever in critically ill patients, developed by a task force of specialist from the American 
College of Critical Care Medicine and the Infectious Diseases Society of America,  “a 
new fever in a patient in the intensive care unit should trigger a careful clinical 
assessment rather than automatic orders for laboratory and radiologic tests. A cost-
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conscious approach for obtaining cultures and imaging studies should be undertaken if 
indicated only after a clinical evaluation.”[57] 
5.3.2 Reduction of Inappropriate Urinary Catheter Insertion and Duration  
The median duration of urinary catheterization prior to urine culture was 9 days with a 
minimum of 2 days and maximum of 63 days. Furthermore, 14.71% of patients had been 
catheterized for greater than 30 days. It has been demonstrated that the risk for CAUTI 
increases by approximately 5% each additional day the urinary catheter remains in the 
patient [23, 26-28] with almost universal bacteriuria with long-term catheterization of 
greater than 30 days [16, 17, 19]. By simply reducing the number of urinary catheters that 
are inserted and decreasing duration of catheterization, we can decrease the number of 
CAUTI events.    
Urinary catheters should only be inserted if appropriately indicated and removed 
as soon as they are no longer needed. In particular, the use of catheters should be limited 
in those with higher risk for CAUTI or mortality from catheterization such as women, 
older patients, and patients with impaired immunity [37]. Catheters should never be used 
for management of incontinence and should only be used in operative patients if 
absolutely necessary. The most common documented reason for Foley necessity in this 
study was the accurate measure of urine output in critically ill patients (66.67%) of which 
20.59% were not on a critical care unit. This implies that documentation of Foley 
necessity is cursory and superficial. Implementation of a system to requires critical 
reassessment for the need for continued catheterization could be beneficial in the 
identification and removal of catheters that are no longer needed. 
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5.4 LIMITATIONS 
This study has some limitations. It is a retrospective chart review analysis and is therefore 
reliant on the quality, completeness, and accuracy of documentation on the part of the all 
caregivers involved in that particular patient’s care. However, excluding clinical signs 
and symptoms, many of the variables collected were objective measures such vital signs 
and laboratory data and should be subject to bias. Additionally, the study was conducted 
at one tertiary care facility in one city in the United States so results may not be 
generalizable to other facilities in different geographic regions or other types of facilities.  
Being as this a retrospective chart review analysis, we do not have information on 
all of the patients that may have experienced a clinician or ID diagnosed CAUTI that was 
not captured under the NHSN definition. This could be valuable information in 
determining the true sensitivity and specificity of the NHSN definition and would a 
worthwhile study to pursue in the future.   
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6.0  CONCLUSION 
The NHSN CAUTI definition does not truly reflect clinician practice. Of all the NHSN 
CAUTI events reported over the three-year period, only two thirds of clinicians and only 
42% of ID consultants diagnosed the NSHN reported CAUTI events as actual UTIs. 
While the NHSN CAUTI definition is important for surveillance purposes, it may be 
overly broad, and not specific enough to measure true clinical CAUTI. The NHSN 
reported CAUTI rate within each hospital is susceptible to the prevalence of fever and 
frequency of obtaining urine cultures in patients with urinary catheters. Therefore, I 
question whether it should be used for national improvement efforts and public reporting 
of hospitals to CMS. That being said, the NHSN CAUTI definition provides the most 
reproducible measure currently available for assessing national rates of CAUTI and 
comparing healthcare facilities. 
 In conclusion, as long as the NSHN-CAUTI definition is used for public 
reporting, it is important to realize that the reported rates are not necessarily reflective of 
infectious complications of urinary catheters or clinical diagnosis. Instead, we should 
look at these rates to identify areas for improvement within the reporting facilities and 
when addressing national improvement efforts. 
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APPENDIX A 
CDC AND NHSN UTI EVENT PROTOCOL AND DEFINITIONS 
 
Appendix A: Urinary Tract Infection Criteria as published by the CDC and NHSN [14] 
 
January 2014  7-4 
Device-associated Module 
 CAUTI 
 
Table 1. Urinary Tract Infection Criteria 
 
Criterion Urinary Tract Infection (UTI) 
 Symptomatic UTI (SUTI) 
Must meet at least 1 of the following criteria: 
1a Patient had an indwelling urinary catheter in place for >2 calendar days, with day 
of device placement being Day 1, and catheter was in place on the date of event  
and 
at least 1 of the following signs or symptoms: fever (>38°C); suprapubic 
tenderness*; costovertebral angle pain or tenderness* 
and 
a positive urine culture of 5 colony-forming units (CFU)/ml and with no more 
than 2 species of microorganisms. Elements of the criterion must occur within a 
timeframe that does not exceed a gap of 1 calendar day between two adjacent 
elements. 
----------------------------------------------------OR------------------------------------------- 
Patient had an indwelling urinary catheter in place for >2 calendar days and had it 
removed the day of or the day before the date of event   
and 
at least 1 of the following signs or symptoms: fever (>38°C); urgency*; 
frequency*; dysuria*; suprapubic tenderness*; costovertebral angle pain or 
tenderness* 
and  
a positive urine culture of 5 colony-forming units (CFU)/ml and with no more 
than 2 species of microorganisms. Elements of the criterion must occur within a 
timeframe that does not exceed a gap of 1 calendar day between two adjacent 
elements.  
*With no other recognized cause 
1b Patient did not have an indwelling urinary catheter that had been in place for >2 
calendar days and in place at the time of or the day before the date of event 
and 
has at least 1 of the following signs or symptoms: fever (>38°C) in a patient that 
is  years of age; urgency*; frequency*; dysuria*; suprapubic tenderness*;  
costovertebral angle pain or tenderness*  
and  
a positive urine culture of 5 CFU/ml and with no more than 2 species of 
microorganisms. Elements of the criterion must occur within a timeframe that 
does not exceed a gap of 1 calendar day between two adjacent elements. 
  
*With no other recognized cause 
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Appendix A: Urinary Tract Infection Criteria as published by the CDC and NHSN  
 
 
 
 
 
January 2014  7-5 
Device-associated Module 
 CAUTI 
 
Criterion Urinary Tract Infection (UTI) 
2a Patient had an indwelling urinary catheter in place for >2 calendar days, with day 
of device placement being Day 1, and catheter was in place on the date of event.  
and 
at least 1 of the following signs or symptoms: fever (>38°C); suprapubic 
tenderness*; costovertebral angle pain or tenderness* 
and 
 at least 1 of the following findings: 
a. positive dipstick for leukocyte esterase and/or nitrite 
b. pyuria (urine specimen with  white blood cells >:%C@/mm3 of unspun 
urine or >5 WBC/high power field of spun urine) 
c. microorganisms seen on Gram’s stain of unspun urine  
and 
a positive urine culture of 3 and <105 CFU/ml and with no more than 2 species 
of microorganisms. Elements of the criterion must occur within a timeframe that 
does not exceed a gap of 1 calendar day between two adjacent elements. 
----------------------------------------------------OR------------------------------------------- 
Patient with an indwelling urinary catheter in place for > 2 calendar days and had 
it removed the day of or the day before the date of event    
and 
at least 1 of the following signs or symptoms: fever (>38°C); urgency*; 
frequency*; dysuria*; suprapubic tenderness*; costovertebral angle pain or 
tenderness* 
and  
at least 1 of the following findings: 
a. positive dipstick for leukocyte esterase and/or nitrite 
b. pyuria (urine specimen with  :%C/mm3 of unspun urine or >5 WBC/high 
power field of spun urine 
c. microorganisms seen on Gram’s stain of unspun urine 
and  
a positive urine culture of 3 and <105 CFU/ml and with no more than 2 species 
of microorganisms. Elements of the criterion must occur within a timeframe that 
does not exceed a gap of 1 calendar day between two adjacent elements. 
 
*With no other recognized cause 
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Criterion Urinary Tract Infection (UTI) 
2b Patient did not have an indwelling urinary catheter that had been in place for >2 
calendar days and in place at the time of, or the day before the date of event   
and 
has at least 1 of the following signs or symptoms: fever (>38°C) in a patient that 
is  years of age; urgency*; frequency*; dysuria*; suprapubic tenderness*;  
costovertebral angle pain or tenderness* 
and  
at least 1 of the following findings: 
a. positive dipstick for leukocyte esterase and/or nitrite 
b. pyuria (urine specimen with  :%C/mm3 of unspun urine or >5 
WBC/high power field of spun urine 
c. microorganisms seen on Gram’s stain of unspun urine 
and  
a positive urine culture of 3 and <105 CFU/ml and with no more than 2 species 
of microorganisms. Elements of the criterion must occur within a timeframe that 
does not exceed a gap of 1 calendar day between two adjacent elements. 
  
*With no other recognized cause 
3 Patient  year of age with** or without an indwelling urinary catheter has at 
least 1 of the following signs or symptoms: fever (>38°C core); hypothermia 
(<36°C core); apnea*; bradycardia*; dysuria*;  lethargy*; vomiting* 
and 
a positive urine culture of 5 CFU/ml and with no more than 2 species of 
microorganisms. Elements of the criterion must occur within a timeframe that 
does not exceed a gap of 1 calendar day between two adjacent elements. 
 
*With no other recognized cause 
** Patient had an indwelling urinary catheter in place for >2 calendar days, with 
day of device placement being Day 1 and catheter was in place on the date of 
event.   
4 Patient  year of age with** or without an indwelling urinary catheter has at 
least 1 of the following signs or symptoms: fever (>38°C core); hypothermia 
(<36°C core); apnea*; bradycardia*; dysuria*; lethargy*; vomiting*  
and  
at least 1 of the following findings: 
a. positive dipstick for leukocyte esterase and/or nitrite 
b. pyuria (urine specimen with  :%C/mm3 of unspun urine or >5 
WBC/high power field of spun urine 
c. microorganisms seen on Gram’s stain of unspun urine 
and  
a positive urine culture of between 3 and <105 CFU/ml and with no more than 
two species of microorganisms. Elements of the criterion must occur within a 
timeframe that does not exceed a gap of 1 calendar day between two adjacent 
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Criterion Urinary Tract Infection (UTI) 
elements. 
 
*With no other recognized cause 
** Patient had an indwelling urinary catheter in place for >2 calendar days, with 
day of device placement being Day 1 and catheter was in place on the date of 
event.   
 
 
Criterion Asymptomatic Bacteremic Urinary Tract Infection (ABUTI) 
 Patient with* or without an indwelling urinary catheter has no signs or symptoms 
(i.e., for any age patient, no fever (>38°C); urgency; frequency; dysuria; 
suprapubic tenderness; costovertebral angle pain or tenderness OR for a patient 
 year of age; no fever (>38°C core); hypothermia (<36°C core); apnea; 
bradycardia; dysuria; lethargy; or vomiting) 
and 
a positive urine culture of 105 CFU/ml and with no more than 2 species of 
uropathogen microorganisms** (see Comments section below) 
and 
a positive blood culture with at least 1 matching uropathogen microorganism to 
the urine culture, or at least 2 matching blood cultures drawn on separate 
occasions if the matching pathogen is a common skin commensal. Elements of the 
criterion must occur within a timeframe that does not exceed a gap of 1 calendar 
day between two adjacent elements. 
 
*Patient had an indwelling urinary catheter in place for >2 calendar days, with 
day of device placement being Day 1, and catheter was in place on the date of 
event.   
**Uropathogen microorganisms are: Gram-negative bacilli, Staphylococcus spp., 
yeasts, beta-hemolytic Streptococcus spp., Enterococcus spp., G. vaginalis, 
Aerococcus urinae, and Corynebacterium (urease positive)+. 
+Report Corynebacterium (urease positive) as either Corynebacterium species 
unspecified (COS) or as C. urealyticum (CORUR) if so speciated. 
 
(See complete list of uropathogen microorganisms at 
http://www.cdc.gov/nhsn/XLS/master-organism-Com-Commensals-
Lists.xlsx#uropathogens) 
Comments x Laboratory cultures reported as “mixed flora” represent at least 2 species of 
organisms. Therefore an additional organism recovered from the same culture, 
would represent >2 species of microorganisms. Such a specimen cannot be 
used to meet the UTI criteria.  
x Urinary catheter tips should not be cultured and are not acceptable for the 
diagnosis of a urinary tract infection. 
x Urine cultures must be obtained using appropriate technique, such as clean 
catch collection or catheterization. Specimens from indwelling catheters 
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Criterion Urinary Tract Infection (UTI) 
elements. 
 
* ith no other recognized cause 
** Patient had an indwelling urinary catheter in place for >2 calendar days, with 
day of device place ent being Day 1 and catheter was in place on the date of 
event.   
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uropathogen icroorganis s** (see o ents section belo ) 
and 
a positive blood culture ith at least 1 atching uropathogen icroorganis  to 
the urine culture, or at least 2 matching blood cultures drawn on separate 
occasions if the matching pathogen is a common skin commensal. Elements of the 
criterion must occur within a timeframe that does not exceed a gap of 1 calendar 
day between two adjacent elements. 
 
*Patient had an indwelling urinary catheter in place for >2 calendar days, with 
day of device placement being Day 1, and catheter was in place on the date of 
event.   
**Uropathogen microorganisms are: Gram-negative bacilli, Staphylococcus spp., 
yeasts, beta-hemolytic Streptococcus spp., Enterococcus spp., G. vaginalis, 
Aerococcus urinae, and Corynebacterium (urease positive)+. 
+Report Corynebacterium (urease positive) as either Corynebacterium species 
unspecified (COS) or as C. urealyticum (CORUR) if so speciated. 
 
(See complete list of uropathogen microorganisms at 
http://www.cdc.gov/nhsn/XLS/master-organism-Com-Commensals-
Lists.xlsx#uropathogens) 
Comments x Laboratory cultures reported as “mixed flora” represent at least 2 species of 
organisms. Therefore an additional organis  recovered from the same culture, 
would represent >2 species of microorganisms. Such a specimen cannot be 
used to meet the UTI criteria.  
x Urinary catheter tips should not be cultured and are not acceptable for the 
diagnosis of a urinary tract infection. 
x Urine cultures must be obtained using appropriate technique, such as clean 
catch collection or catheterization. Specimens from indwelling catheters 
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should be aspirated through the disinfected sampling ports. 
x In infants, urine cultures should be obtained by bladder catheterization or 
suprapubic aspiration; positive urine cultures from bag specimens are 
unreliable and should be confirmed by specimens aseptically obtained by 
catheterization or suprapubic aspiration. 
x Urine specimens for culture should be processed as soon as possible, 
preferably within 1 to 2 hours.  If urine specimens cannot be processed within 
30 minutes of collection, they should be refrigerated, or inoculated into 
primary isolation medium before transport, or transported in an appropriate 
urine preservative. Refrigerated specimens should be cultured within 24 hours. 
x Urine specimen labels should indicate whether or not the patient is 
symptomatic. 
x Report only pathogens in both blood and urine specimens for ABUTI. 
x Report Corynebacterium (urease positive) as either Corynebacterium species 
unspecified (COS) or as C. urealyticum (CORUR) if speciated. 
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